Skip to main content
. 2017 Apr 18;9(4):373–377. doi: 10.4168/aair.2017.9.4.373

Table 1. Characteristics of the study patients of the AITD (n=3,659) and control group (n=18,295).

Variables Control group (n=18,295) AITD group (n=3,659) P value
CSU 0.001
 No event 17,585 (96.1) 3,436 (93.9)
 Event 710 (3.9) 223 (6.1)
Age group (year) 1.000
 20-39 6,805 (37.2) 1,361 (37.2)
 40-64 9,570 (52.3) 1,914 (52.3)
 >65 1,920 (10.5) 384 (10.5)
Gender 1.000
 Male 3,520 (19.2) 704 (19.2)
 Female 14,775 (80.8) 2,995 (80.8)
Household income (%) <0.001
 0–20 3,100 (18.3) 443 (12.1)
 21–100 15,195 (83.1) 3,216 (87.9)
Resident area <0.001
 Urban 8,643 (47.2) 1,849 (50.5)
 Rural 9,652 (52.8) 1,810 (49.5)
Comorbidities
 Type 2 DM 939 (5.3) 297 (8.3) <0.001
 Hypertension 2,910 (16.3) 942 (26.4) <0.001
 Dyslipidemia 1,220 (6.8) 478 (13.4) <0.001
 Allergic rhinitis 4,207 (23.0) 1,214 (33.2) <0.001
 Atopic dermatitis 273 (1.5) 117 (3.2) <0.001
 Asthma 1,195 (6.5) 364 (10.0) <0.001

Data are presented as number of patients (%).

AITD, autoimmune thyroid disease; DM, diabetes mellitus.